Evidence mapPaperPMID 38211441Full record

ArticleRedox biology2024

Identification of novel F

Ginger L Milne, Marina S Nogueira, Benlian Gao, Stephanie C Sanchez, Warda Amin, Sarah Thomas, Camille Oger, Jean-Marie Galano, Harvey J Murff, Gong Yang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Ten "Cheat Codes" for Measuring Oxidative Stress in Humans.Antioxidants (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Ginger L MilneDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232-6602, USA. Electronic address: ginger.milne@vumc.org.
Marina S NogueiraDivision of Epidemiology, Department of Medicine, Vanderbilt Univiersity Medical Center, Nashville, TN, 37232, USA.
Benlian GaoDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232-6602, USA.
Stephanie C SanchezDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232-6602, USA.
Warda AminDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232-6602, USA.
Sarah ThomasDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232-6602, USA.
Camille OgerInstitut des Biomolécules Max Mousseron, IBMM, UMR 5247, Pôle Chimie Balard Recherche, Université de Montpellier, CNRS, ENSCM. Montpellier, France.
Jean-Marie GalanoInstitut des Biomolécules Max Mousseron, IBMM, UMR 5247, Pôle Chimie Balard Recherche, Université de Montpellier, CNRS, ENSCM. Montpellier, France.
Harvey J MurffDivision of Geriatric Medicine, Department of Medicine, Vanderbilt Univiersity Medical Center, Nashville, TN, 37232, USA.
Gong YangDivision of Epidemiology, Department of Medicine, Vanderbilt Univiersity Medical Center, Nashville, TN, 37232, USA.
Thierry DurandInstitut des Biomolécules Max Mousseron, IBMM, UMR 5247, Pôle Chimie Balard Recherche, Université de Montpellier, CNRS, ENSCM. Montpellier, France.
Vanderbilt University Medical Center · USCentre National de la Recherche Scientifique · FRVanderbilt University · US

Funding

Time-dependent and bidirectional effect of oxidative stress - a missing piece of the free radical theory of cancer and its potential implicationsR01CA237895 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · 2021 to 2025
$2.7M
Vanderbilt Diabetes Research CenterP30DK020593 · VANDERBILT UNIVERSITY MEDICAL CENTER · 2025 to 2025
$1.8M
NCI NIH HHS R01 CA237895NIDDK NIH HHS P30 DK020593
6 · The paper itself

Abstract

UDP-glucuronosyltransferases (UGTs) catalyze the conjugation of glucuronic acid with endogenous and exogenous lipophilic small molecules to facilitate their inactivation and excretion from the body. This represents approximately 35 % of all phase II metabolic transformations. Fatty acids and their oxidized eicosanoid derivatives can be metabolized by UGTs. F

Indexed as

F2-IsoprostanesIsoprostanesEicosanoidsGlucuronidesHumansOxidative StressUridine DiphosphateEicosanoidsF2-IsoprostanesGlucuronidesIsoprostanesUridine DiphosphateFish oilGlucuronidationIsoprostanesMass spectrometryMetabolism

Identifiers

PMID38211441
PMCPMC10821610
OpenAlexW4390577367

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.